Navigation Links
Quitting the smoking habit

According to a new study it is observed that antidepressants used to aid people quit smoking are more effective when combined with a psychological program. The down side, researchers add, is neither approach appears// to help people quit and stay quit over the long-term.

Researchers from the University of California, noted better short term and intermittent quit rates among smokers who took either sustained-release bupropion hydrochloride (Zyban) or nortirptyline hydrochloride (a lower-cost generic drug) than those who took a placebo. But, they found, the best quit rates occurred among those who took one of the stop smoking medications and also took part in a counseling program run by internal medicine and psychiatric residents.

The counseling sessions consisted of medical management sessions in which the internal medicine residents reviewed the reasons for prescribing the antidepressants and followed up to see if people were complying with the treatment. Psychiatric residents conducted group sessions covering education on smoking cessation and helped participants develop a personal plan for quitting, which was revised as the year progressed.

Despite intermittent success, however, none of the treatments in the study was able to help people stay off cigarettes consistently for the entire study period. By the one-year follow-up, people taking the medications, either alone or in combination with counseling, were no more likely to have abstained from cigarettes for the whole year than those who took the sham pill. The researchers thereby observe that more effective treatments are needed to assist people give up smoking for good.


'"/>




Page: 1

Related medicine news :

1. Quitting smoking stops lung decline
2. Women Benefit More from Quitting Smoking than Men
3. Quitting Smoking Made Easy By Track Of New Chemical
4. Quitting Psychotherapy Midway May Be Preventable
5. Taylor & Campbell Quitting NHS
6. Taylor & Campbell Quitting NHS
7. Smokers are Prone to Weight Gain After Quitting
8. Save your Vision with Fish Oil and Quitting Smoking
9. Women Smokers Fear Quitting Will Lead to Weight Gain
10. For Smokers Only: is Quitting = Cutting Down?? a grave Issue
11. Exercise can Reduce Smokers Lung Cancer Risk but the Most Important is Quitting Smoking – a Study Report
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:8/21/2017)... (PRWEB) , ... August 21, 2017 , ... ... services business of UnitedHealth Group (NYSE: UNH), has made a multi-million dollar partnership ... affected by post-traumatic stress disorder (PTSD) and traumatic brain injuries (TBI) over the ...
(Date:8/20/2017)... ... ... Are you an adult with gluten intolerance or Celiac disease living with ... participating in a research study that focuses on family interactions when dealing with dietary ... aspects of adults who have gluten sensitivities who cohabitate with other adults who may ...
(Date:8/19/2017)... , ... August 19, 2017 , ... ... that it is the first organization with pending recognition status from the Centers ... Program (“DPP”) via group telehealth classes and live video conferencing. , The ...
(Date:8/19/2017)... ... August 19, 2017 , ... ... joined its Orlando location as an interventional pain management physician. He brings a ... the treatment of migraine headaches, and significant experience in spinal cord stimulation for ...
(Date:8/18/2017)... ... August 18, 2017 , ... ... International, LLC (“Quick”), a highly specialized asset-light logistics provider of complex transport ... a definitive agreement to purchase Unitrans International Corporation, a division of Roadrunner ...
Breaking Medicine News(10 mins):
(Date:7/26/2017)... , July 26, 2017 E.I. Medical Imaging ... the Bimini SharkLab to custom design the worlds first ultrasound system ... sharks in their native habitat. In preparation for a ... Channel,s Shark Week, Dr. Guttridge approached EIMI with the ... diagnosis directly to hammerhead sharks underwater. ...
(Date:7/26/2017)... , July 26, 2017 Sancilio Pharmaceuticals Company, ... our clinical trial evaluating Altemia TM , an oral ... and Sickle Cell Disease (SCD). The SCOT Trial, is ... efficacy and safety of Altemia TM in pediatric ... under US IND 125274. ...
(Date:7/25/2017)... CAMBRIDGE, Massachusetts , July 25, 2017 /PRNewswire/ ... drugs to treat rare nervous system diseases, has concluded a ... and market the drug SOM0226 against transthyretin amyloidosis (ATTR). Before ... promising results in a Phase 2 study conducted in ... in the United States ...
Breaking Medicine Technology: